The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory
- 1 November 1993
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 57 (2) , 143-153
- https://doi.org/10.1016/0166-4328(93)90130-i
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivoLife Sciences, 1993
- The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodentsPharmacology Biochemistry and Behavior, 1991
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- The Memory Deficits in Alzheimer-Type Dementia: A ReviewThe Quarterly Journal of Experimental Psychology Section A, 1986
- Potential Animal Models for Senile Dementia of Alzheimer's Type, with Emphasis on AF64A-Induced CholinotoxicityAnnual Review of Pharmacology and Toxicology, 1986
- Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in ratsPsychopharmacology, 1985
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIAThe Lancet, 1977
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976